Investigating the role of artemin in oral cancer pain and development
Artemin overexpression in oral cancer pain and carcinogenesis
This study is looking at how a gene called artemin affects the growth of oral cancer and the pain that comes with it, to see if targeting this gene can help improve treatment and make patients feel better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10914113 on NIH RePORTER |
What this research studies
This research focuses on understanding how the gene artemin contributes to both the development of oral cancer and the severe pain experienced by patients. By examining the mechanisms through which artemin operates in the cancer microenvironment, the study aims to identify whether targeting this gene can help manage cancer progression and alleviate pain. The approach involves precision medicine, tailoring treatments based on individual genetic profiles to improve outcomes for patients suffering from oral cancer. The research will explore the dual role of artemin as both a cancer-promoting gene and a pain mediator.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with oral cancer who are experiencing chronic pain related to their condition.
Not a fit: Patients with oral cancer who do not experience significant pain or those with other types of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively manage oral cancer and reduce associated pain, improving patients' quality of life.
How similar studies have performed: Previous research has shown promise in targeting specific oncogenes for cancer treatment, suggesting that this approach may yield beneficial results.
Where this research is happening
New York, United States
- New York University — New York, United States (Active)
Researchers
- Principal investigator: Albertson, Donna G — New York University
- Study coordinator: Albertson, Donna G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.